Carmell Therapeutics Corp
Biotechnology company · Pittsburgh, Pennsylvania, United States
Carmell Therapeutics Corp is a biotechnology company headquartered in Pittsburgh, Pennsylvania, United States. Its earliest recorded incorporation is in 2008. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $1.2 million in total, most recently in 2014. It has reported private securities offerings to the US SEC, most recently $2.4 million sold in a notice filed in 2020.
Carmell Therapeutics at a glance
What does Carmell Therapeutics do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $1.2 million in total (2008 to 2014).
Private fundraising reported to the SEC
19 Form D notices; the most recent reported $2.4 million sold (2020).
Frequently asked questions about Carmell Therapeutics
Where is Carmell Therapeutics headquartered?
Carmell Therapeutics Corp is headquartered in Pittsburgh, Pennsylvania, United States.
What does Carmell Therapeutics do?
Carmell Therapeutics Corp is a biotechnology company.
When was Carmell Therapeutics founded?
The earliest incorporation on record for Carmell Therapeutics Corp is in 2008, according to public company registers.
Similar companies
- Krystal Biotech, Inc.Pittsburgh, Pennsylvania, United States
- CytoAgents, Inc.Pittsburgh, Pennsylvania, United States
- Knopp Biosciences LLCPittsburgh, Pennsylvania, United States
- Noveome Biotherapeutics, Inc.Pittsburgh, Pennsylvania, United States
- Cohera Medical IncPittsburgh, Pennsylvania, United States
- Renerva, Inc.Pittsburgh, Pennsylvania, United States
- Globin Solutions, Inc.Pittsburgh, Pennsylvania, United States
- Celsense IncPittsburgh, Pennsylvania, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences